<DOC>
	<DOCNO>NCT02212080</DOCNO>
	<brief_summary>This study first human study investigate safety , tolerability pharmacokinetics ascend single dos BAY1214784 use placebo control , randomize , single center design . In addition bioavailability two different liquid formulation compare .</brief_summary>
	<brief_title>First Human Study Healthy Volunteers Investigate Safety , Tolerability Pharmacokinetics BAY1214784</brief_title>
	<detailed_description />
	<criteria>Healthy female subject Age 45 65 year Body mass index ( BMI ) above/equal 20 below/equal 30 kg/m2 Postmenopausal state Incompletely cure preexisting disease assume absorption , distribution , metabolism , elimination effect study drug normal Known suspect malignant benign tumor Known suspect liver disorder , relevant kidney disease , know cardiovascular disease , know metabolic disorder Regular use medicine</criteria>
	<gender>Female</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2015</verification_date>
</DOC>